IRIS
SCARALE, MARIA GIOVANNA
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
EU - Europa 164
NA - Nord America 127
AS - Asia 15
Continente sconosciuto - Info sul continente non disponibili 2
OC - Oceania 1
Totale 309
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 126
SE - Svezia 86
IT - Italia 66
CN - Cina 9
FI - Finlandia 6
DE - Germania 3
EU - Europa 2
IE - Irlanda 2
JP - Giappone 2
TR - Turchia 2
AM - Armenia 1
AU - Australia 1
CA - Canada 1
IN - India 1
NL - Olanda 1
Totale 309
Salva come PNG Salva come JPEG
Città #
Milan 24
Lawrence 23
Princeton 23
Shanghai 9
Rome 7
Helsinki 6
Arona 4
Ashburn 4
New York 4
Ponte Lambro 3
Afragola 2
Bornova 2
Borås 2
Crotone 2
Dublin 2
Fonte Nuova 2
Los Angeles 2
Lumezzane 2
Macerata 2
Miyazaki 2
Schio 2
Amsterdam 1
Boardman 1
Menlo Park 1
Pisa 1
Pune 1
San Giovanni Rotondo 1
Seattle 1
Staten Island 1
Sydney 1
Toronto 1
Totale 139
Salva come PNG Salva come JPEG
Nome #
TRI-SCORE: a single-Centre validation study 50
A serum resistin and multi-cytokine inflammatory pathway is associated with and helps predict all-cause mortality in type 2 diabetes: a step toward precision medicine 17
A simulation study on the use of response-adaptive randomized designs 16
Combined Effect of High Sensitive C-Reactive Protein (hs-CRP) and Serum Amyloid Component P (SAP) on Mortality Rate in Type 2 Diabetes 14
On the Combined Effect of C-Reactive Protein (CRP) and Serum Amyloid Component P (SAP) on Mortality Risk in Type 2 Diabetes 14
Serum amyloid component P improves the ability of C-reactive protein to predict all-cause mortality in patients with type 2 diabetes 14
Pathogenic variants of MODY-genes in adult patients with early-onset type 2 diabetes 14
Combined effect of high sensitive C-reactive protein and serum amyloid component P on mortality rate in patients with type 2 diabetes 13
Circulating metabolites significantly improve the prediction of renal dysfunction in type 2 diabetes 12
A Serum Resistin and Multicytokine Inflammatory Pathway Is Linked with and Helps Predict All-cause Death in Diabetes 12
GALNT2 as a novel modulator of adipogenesis and adipocyte insulin signaling 12
Contribution of rare and common genetic variants to early-onset type 2 diabetes 12
Morphological and molecular characterization of GALNT2-mediated adipogenesis 11
Estimation of Mortality Risk in Type 2 Diabetic Patients (ENFORCE): An Inexpensive and Parsimonious Prediction Model 11
The Adiponectin-Mortality Paradox—A Systematic Review and Meta-analysis 11
Circulating adiponectin levels are paradoxically associated with mortality rate: A systematic review and meta-analysis 11
Urn models for response-adaptive randomized designs: a simulation study based on a non-adaptive randomized trial 10
Urn Models in Clinical Trials 10
Insulin resistance and risk of major vascular events and all-cause mortality in type 1 diabetes: A 10-year follow-up study 10
Contribution of rare variants in monogenic diabetes-genes to early-onset type 2 diabetes 9
Insights from molecular characterization of adult patients of families with multigenerational diabetes 9
Pharmacogenetics of oral antidiabetes drugs: Evidence for diverse signals at the IRS1 locus 9
Neochordae implantation versus leaflet resection in mitral valve posterior leaflet prolapse and dilated left ventricle: a propensity score matching comparison with long-term follow-up 8
Profiling Covid-19 patients with respect to level of severity: an integrated statistical approach 8
The synergic association of hs-CRP and serum amyloid P component in predicting all-cause mortality in patients with type 2 diabetes 8
Variability in genes regulating Vitamin D metabolism is associated with Vitamin D levels in type 2 diabetes 8
Circulating Metabolites Associate With and Improve the Prediction of All-Cause Mortality in Type 2 Diabetes 7
COVID-19 vaccines effect on blood pressure 7
Role of urocortin in pregnancy: An update and future perspectives 6
Current state-of-the-art and gaps in platform trials: 10 things you should know, insights from EU-PEARL 5
Impact of age, comorbidities and relevant changes on surveillance strategy of intraductal papillary mucinous neoplasms: A competing risk analysis 1
Totale 359
Salva come PNG Salva come JPEG
Categoria #
all - tutte 5.105
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 5.105
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/202245 0 0 0 0 0 0 3 32 4 3 1 2
2022/2023183 59 43 7 0 2 20 2 17 6 2 22 3
2023/2024131 4 4 31 18 17 22 9 12 8 3 3 0
Totale 359